Unknown NA INTERVENTIONAL 2-arm NCT03455205

Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Chemo Patients With Digestive Tract .

The Efficacy and Safety of Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Chemo Patients With Digestive Tract Were Prospectively, Randomized Blind, Multicenter Clinical Trials

Sponsor: Livzon Pharmaceutical Group Inc.

Conditions Digestive Tract

Interventions 0.9%sodium chloride shenqifuzheng

Updated 6 times since 2018 Last updated: Feb 27, 2018 Started: Dec 24, 2017 Primary completion: Dec 30, 2019 Completion: Dec 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Digestive Tract and is currently ongoing. Livzon Pharmaceutical Group Inc. leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Feb 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Feb 2020 [monthly]

Recruiting NA

▶ Show 1 earlier version

Mar 2018 — Jun 2018 [monthly]

Recruiting NA

First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Livzon Pharmaceutical Group Inc.
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

Data source: Livzon Pharmaceutical Group Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China